Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Discrepancy in current central serous chorioretinopathy classification.

Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.

Br J Ophthalmol. 2018 Jul 12. pii: bjophthalmol-2018-312435. doi: 10.1136/bjophthalmol-2018-312435. [Epub ahead of print]

PMID:
30002069
2.

Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy.

Teke MY, Elgin U, Nalcacioglu-Yuksekkaya P, Sen E, Ozdal P, Ozturk F.

Int J Ophthalmol. 2014 Apr 18;7(2):350-4. doi: 10.3980/j.issn.2222-3959.2014.02.29. eCollection 2014.

3.

Sensitivity and specificity of multispectral imaging in detecting central serous chorioretinopathy.

Zhu X, Cheng Y, Pan X, Jin E, Li S, Zhao M, Li X.

Lasers Surg Med. 2017 Jul;49(5):498-505. doi: 10.1002/lsm.22619. Epub 2016 Dec 21.

PMID:
28000244
4.

Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.

Demirok G, Kocamaz F, Topalak Y, Altay Y, Sengun A.

Int Ophthalmol. 2017 Apr;37(2):409-416. doi: 10.1007/s10792-016-0278-4. Epub 2016 Jun 20.

PMID:
27324370
5.

En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Ferrara D, Mohler KJ, Waheed N, Adhi M, Liu JJ, Grulkowski I, Kraus MF, Baumal C, Hornegger J, Fujimoto JG, Duker JS.

Ophthalmology. 2014 Mar;121(3):719-26. doi: 10.1016/j.ophtha.2013.10.014. Epub 2013 Nov 26.

6.

The hyper-fluorescent transitional bands in ultra-late phase of indocyanine green angiography in chronic central serous chorioretinopathy.

Hua R, Yao K, Xia F, Li J, Guo L, Yang G, Tao J.

Lasers Surg Med. 2016 Mar;48(3):260-3. doi: 10.1002/lsm.22434. Epub 2015 Oct 19.

PMID:
26482206
7.

Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Bonini Filho MA, de Carlo TE, Ferrara D, Adhi M, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK.

JAMA Ophthalmol. 2015 Aug;133(8):899-906. doi: 10.1001/jamaophthalmol.2015.1320.

8.

A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.

Lai FH, Ng DS, Bakthavatsalam M, Chan VC, Young AL, Luk FO, Tsang CW, Brelén ME.

Am J Ophthalmol. 2016 Oct;170:91-99. doi: 10.1016/j.ajo.2016.07.026. Epub 2016 Aug 9.

PMID:
27519561
9.

Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.

Iacono P, Battaglia PM, Papayannis A, La Spina C, Varano M, Bandello F.

Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1889-97. doi: 10.1007/s00417-014-2899-5. Epub 2015 Jan 8.

PMID:
25563727
10.

Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.

Shin YU, Lee BR.

Am J Ophthalmol. 2012 Jul;154(1):155-163.e4. doi: 10.1016/j.ajo.2012.01.023. Epub 2012 Apr 13.

PMID:
22503695
11.

Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy.

Ozmert E, Batioğlu F.

Ophthalmologica. 2009;223(4):263-8. doi: 10.1159/000210386. Epub 2009 Apr 2.

PMID:
19339810
12.

Bilateral simultaneous central serous chorioretinopathy in a teenage girl with systemic arterial hypertension.

Alwassia AA, Adhi M, Duker JS.

Int Ophthalmol. 2013 Feb;33(1):79-82. doi: 10.1007/s10792-012-9624-3. Epub 2012 Sep 16.

13.
14.

Retinal vessels functionality in eyes with central serous chorioretinopathy.

Tomasso L, Benatti L, Rabiolo A, Carnevali A, Zucchiatti I, Querques L, Bandello F, Querques G.

Br J Ophthalmol. 2018 Feb;102(2):210-214. doi: 10.1136/bjophthalmol-2017-310398. Epub 2017 Jun 9.

PMID:
28600300
15.

Is myopia a protective factor against central serous chorioretinopathy?

Manayath GJ, Arora S, Parikh H, Shah PK, Tiwari S, Narendran V.

Int J Ophthalmol. 2016 Feb 18;9(2):266-70. doi: 10.18240/ijo.2016.02.16. eCollection 2016.

16.

Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.

Song IS, Shin YU, Lee BR.

Am J Ophthalmol. 2012 Aug;154(2):366-375.e4. doi: 10.1016/j.ajo.2012.02.031. Epub 2012 May 23.

PMID:
22633348
17.

Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy.

Papadia M, Jeannin B, Herbort CP.

J Ophthalmic Vis Res. 2015 Jul-Sep;10(3):303-8. doi: 10.4103/2008-322X.170352.

18.

FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.

Dysli C, Berger L, Wolf S, Zinkernagel MS.

Retina. 2017 Nov;37(11):2151-2161. doi: 10.1097/IAE.0000000000001452.

19.

[A new approach for studying the retinal and choroidal circulation].

Yoneya S.

Nippon Ganka Gakkai Zasshi. 2004 Dec;108(12):836-61; discussion 862. Review. Japanese.

PMID:
15656089
20.

[Serous central chorioretinopathy. Acute autofluorescence of the pigment epithelium of the eye].

von Rückmann A, Schmidt KG, Fitzke FW, Bird AC, Jacobi KW.

Ophthalmologe. 1999 Jan;96(1):6-10. German.

PMID:
10067327

Supplemental Content

Support Center